Evolus, Inc. (EOLS) Stock Profile — Insider Trades & Financials

Revenue$90.3M

Net Income$130.0K

EPS$-0.80

Gross Margin65.7%

Market Cap$266.1M

Price Performance

Historical data including institutional events

Loading price data...

Company Profile

David Moatazedi

CEO & Executive Director

Evolus, Inc., a performance beauty company, delivers products in the cash-pay aesthetic market in the United States, Canada, Europe, and Australia. It offers Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults; and Evolysse, a collection of injectable hyaluronic acid gels, which includes various products, such as mid face, nasolabial folds, lips and eyes. The company was incorporated in 2012 and is headquartered in Newport Beach, California.

Founded: 2012
Employees: 334
Headquarters: Newport Beach, California, United States

⚡

Core Efficiency

ROE?

-0.56%

ROA?

0.06%

D/E Ratio?

-10.78

Op. Margin?

4.67%

📊

Profitability Ratios

Net Margin?

0.14%

Loading company sections...

Evolus, Inc.

Price Performance

Company Profile

Core Efficiency

Profitability Ratios

Core Efficiency

Profitability Ratios

Earnings Calendar

Data Freshness